Mobilat (Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid)

Mucopolysaccharide Polysulfuric Acid Ester and Salicylic Acid, the active ingredients in Mobilat, are dermatological agents presented as a topical formulation for intraepidermal use. They help to promote keratinocyte desquamation and provide anti‑inflammatory effects in patients with common skin disorders.

GNH USA supplies Mobilat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from comprehensive regulatory support and consistent product availability across EU and international markets.

Mobilat is used in dermatology to address disorders characterized by abnormal keratinization and inflammation. - Acne vulgaris: reduces comedones and inflammation through keratinocyte exfoliation. - Psoriasis: softens plaques and decreases scaling by promoting desquamation. - Seborrheic dermatitis: alleviates redness and flaking by combining keratolytic and anti‑inflammatory actions.

Topical application of Mobilat may cause local skin reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Skin irritation: transient redness or burning at the application site. - Dryness: increased transepidermal water loss leading to flaky skin. - Peeling: mild desquamation as the keratolytic effect progresses. - Itching: occasional pruritus during early treatment. - Erythema: mild redness that usually subsides with continued use. - Stinging sensation: brief discomfort upon initial application.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or vesiculation requiring medical attention. - Extensive skin ulceration: deep erosion beyond superficial layers, especially with overuse. - Systemic salicylate toxicity: rare but possible if large skin areas are treated, presenting with tinnitus, headache, or nausea. - Photosensitivity: heightened skin reaction to sunlight. - Secondary infection: bacterial colonisation of compromised skin.

Before using Mobilat, consider the following safety measures. - Avoid use on broken or inflamed skin: may increase irritation and systemic absorption. - Limit application area: applying to large surface areas can raise risk of systemic effects. - Use sunscreen or protective clothing: salicylic acid can increase photosensitivity. - Discontinue if severe irritation occurs: seek medical advice promptly. - Pregnant or breastfeeding individuals: consult a healthcare professional before use. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Mobilat may interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use of other keratolytics (e.g., benzoyl peroxide): can cause excessive irritation or chemical burns. - Systemic salicylates (e.g., aspirin): may increase risk of salicylate toxicity when large skin areas are treated.

Moderate Interactions (Monitor Closely): - Topical retinoids: combined use may enhance skin peeling and irritation. - Topical corticosteroids: may reduce anti‑inflammatory benefit of the mucopolysaccharide component. - Other irritant cosmetics or fragrances: can exacerbate local sensitivity. - Antifungal creams: overlapping mechanisms may affect skin barrier integrity.